Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Halozyme Therapeutics, Inc. - Common Stock (NQ:HALO)

65.19 +0.56 (+0.87%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,414,861
Open 64.10
Bid (Size) 63.74 (1)
Ask (Size) 67.00 (2)
Prev. Close 64.63
Today's Range 63.84 - 65.49
52wk Range 42.01 - 79.50
Shares Outstanding 142,334,900
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Insights into Halozyme Therapeutics's Upcoming Earnings
 
Via Benzinga
Halozyme Therapeutics Inc (NASDAQ:HALO) Fits a Proven Growth Investing Method
Halozyme Therapeutics shows strong growth metrics, including soaring earnings, sales, and a high ROE, fitting a proven growth investing strategy. 
Via Chartmill

Performance

YTD
+35.8%
+35.8%
1 Month
-11.1%
-11.1%
3 Month
+8.7%
+8.7%
6 Month
+8.6%
+8.6%
1 Year
+28.9%
+28.9%

More News

Read More
Koa Wealth Liquidates All 68K IIPR Shares Valued at $3.8 Million
Via The Motley Fool
Topics Cannabis
HALOZYME THERAPEUTICS INC (NASDAQ:HALO) Combines Strong Growth Momentum with Technical Breakout Setup
Via Chartmill
Halozyme Therapeutics Inc (NASDAQ:HALO) Presents a Compelling Value Investment Case
Via Chartmill
Halozyme Therapeutics Inc (NASDAQ:HALO) Offers an Affordable Growth Profile
Via Chartmill
Halozyme Therapeutics Inc (NASDAQ:HALO): A Growth Stock Poised for a Breakout
Via Chartmill
The Analyst Verdict: Halozyme Therapeutics In The Eyes Of 10 Experts
Via Benzinga
Halozyme Therapeutics Inc (NASDAQ:HALO) Demonstrates Strong Growth and Profitability
Via Chartmill
Halozyme Therapeutics Inc (NASDAQ:HALO): A Prime Candidate for Affordable Growth
Via Chartmill
Forecasting The Future: 7 Analyst Projections For Halozyme Therapeutics
Via Benzinga
Halozyme Therapeutics Inc (NASDAQ:HALO) Presents a High-Growth Momentum and Technical Breakout Opportunity
Via Chartmill
Halozyme Therapeutics Inc (NASDAQ:HALO) Embodies Navellier's Growth Investing Principles
Via Chartmill
Halozyme Therapeutics Inc (NASDAQ:HALO) Presents a Compelling Case for Value Investors
Via Chartmill
United Therapeutics Price Strength Rating Jumps After Its Stock Soared 33% Last Week On Positive Drug Test Results
Via Investor's Business Daily
Topics ETFs
Halozyme Therapeutics Inc (NASDAQ:HALO) Fits Minervini's Trend Template with Strong Technicals and Earnings Momentum
Via Chartmill
HALOZYME THERAPEUTICS INC (NASDAQ:HALO) Offers Affordable Growth With Strong Fundamentals
Via Chartmill
HALOZYME THERAPEUTICS INC (NASDAQ:HALO) Stands Out in Navellier's Growth Screen
Via Chartmill
Argenx Stock Hits Record High After Reporting 664% Earnings Surge; This Rating Upgraded
Via Investor's Business Daily
Topics ETFs
HALOZYME THERAPEUTICS INC (NASDAQ:HALO) Stands Out as a Top Undervalued Stock with Strong Fundamentals
Via Chartmill
What 7 Analyst Ratings Have To Say About Halozyme Therapeutics
Via Benzinga
HALOZYME THERAPEUTICS INC (NASDAQ:HALO) – A Top Pick for Affordable Growth Investors
Via Chartmill
What Does the Market Think About Halozyme Therapeutics?
Via Benzinga
HALOZYME THERAPEUTICS INC (NASDAQ:HALO) Fits Louis Navellier’s High-Growth Stock Criteria
Via Chartmill
Halozyme (HALO) Q2 EPS Jumps 69%
Via The Motley Fool
Topics Intellectual Property

Frequently Asked Questions

Is Halozyme Therapeutics, Inc. - Common Stock publicly traded?
Yes, Halozyme Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Halozyme Therapeutics, Inc. - Common Stock trade on?
Halozyme Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Halozyme Therapeutics, Inc. - Common Stock?
The ticker symbol for Halozyme Therapeutics, Inc. - Common Stock is HALO on the Nasdaq Stock Market
What is the current price of Halozyme Therapeutics, Inc. - Common Stock?
The current price of Halozyme Therapeutics, Inc. - Common Stock is 65.19
When was Halozyme Therapeutics, Inc. - Common Stock last traded?
The last trade of Halozyme Therapeutics, Inc. - Common Stock was at 10/31/25 04:00 PM ET
What is the market capitalization of Halozyme Therapeutics, Inc. - Common Stock?
The market capitalization of Halozyme Therapeutics, Inc. - Common Stock is 9.28B
How many shares of Halozyme Therapeutics, Inc. - Common Stock are outstanding?
Halozyme Therapeutics, Inc. - Common Stock has 9B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.